Search clinical trials for: rhG-CSF 5ug/kg/day

Total 750 results

Jiangsu HengRui Medicine Co., Ltd.

Completed

A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy

Breast Cancer | Neutropenia | Febrile Neutropenia

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy

NSCLC | Neutropenia | Febrile Neutropenia

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Phase II Study Comparing Pegylated rhG-CSF（HHPG-19K） and rhG-CSF in Breast Cancer Patients Receiving Chemotherapy

Breast Cancer | Neutropenia | Febrile Neutropenia

China
Hangzhou Jiuyuan Gene Engineering Co. Ltd.,
The First Affiliated Hospital with Nanjing Medical University; Cancer Institute... and other collaborators

Unknown

Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia (PEG-rhG-CSF)

Neutropenia

China
Dong-A ST Co., Ltd.

Completed

A Study to Evaluate the Efficacy, Safety and Immunogenicity of Leucostim® Versus Neupogen® in Breast Cancer Patients

Breast Cancer

Indonesia
Xiamen Amoytop Biotech Co., Ltd.

Completed

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy

Breast Cancer | Non Small Cell Lung Cancer

China
Air Force Military Medical University, China

Unknown

To Evaluate the Efficacy and Safety of PEG-rhG-CSF（Jinyouli®） in Reducing Neutropenia in Patients With Cervical Cancer

Cervical Cancer

China
The First Hospital of Jilin University

Recruiting

Mecapegfilgrastim(PEG-G-CSF) for Prophylaxis of Chemotherapy-induced Neutropenia in Patients With Lymphoma

Lymphoma | Chemotherapy-induced Neutropenia

China
Peking University

Unknown

PEG-rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation

Lymphoma

China
Sun Yat-sen University
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

PEG-rhG-CSF Compared With rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation

Lymphoma
Chongqing University Cancer Hospital
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Recruiting

Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells

Lymphoma

China
Tianjin SinoBiotech Ltd.
Peking University Cancer Hospital & Institute

Completed

Safety and Efficacy Studies of rHSA/GCSF Fusion Protein For Injection to Treat Neutropenia

Cancer | Tumor | Underdose (Unintentional)

China
Xiamen Amoytop Biotech Co., Ltd.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Completed

Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving Chemotherapy

Non-Myeloid Malignancy

China
Xiamen Amoytop Biotech Co., Ltd.
Shanghai Jiao Tong University Affiliated First People's Hospital

Completed

Antifugal Effect of Recombinant Human Granulocyte-macrophage Stimulating Factor (rhGM-CSF) in Patients Post Allo-HSCT

Mycoses

China
Ning Huang

Not yet recruiting

A Clinical Study of Autologous Peripheral Blood Stem Cell Mobilization for PEG-G-CSF

Granulocyte Colony-stimulating Factor | Stem Cell Mobilization
Ruijin Hospital

Unknown

Cost-Effectiveness Study of PEG-rhG-CSF in Prophylactic Treatment of Neutropenia After Chemotherapy in Lymphoma

Lymphoma, Non-Hodgkin | Granulocyte Colony-Stimulating Factor | Cost-Benefit Analysis

China
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Beijing Friendship Hospital

Unknown

Evaluate the Efficacy and Safety of PEG-rhG-CSF in Patients With Hemophagocytic Syndrome

Hemophagocytic Syndrome

China
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Children's Hospital of Fudan University

Unknown

Evaluate the Efficacy and Safety of the Prophylactic Use of PEG-rhG-CSF in Children With Hematological Malignancies

Lymphoma | Leukemia

China
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Completed

PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy

Breast Cancer
Zhongnan Hospital

Not yet recruiting

The Value of Peripheral Blood CD34+ Cell Dynamics Monitoring in Autologous Hematopoietic Stem Cell Transplant Mobilization

Granulocyte Colony-Stimulating Factor

China
Ou Bai, MD/PHD

Not yet recruiting

the Efficacy and Safety of PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells in Lymphoma

Lymphoma

China
Chongqing University Cancer Hospital

Completed

Study on the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia During Concurrent Chemoradiotherapy of Cervical Cancer

Cervical Cancer

China
Adello Biologics, LLC
inVentiv Health Clinical

Completed

Study Comparing TPI-120 and Neulasta Administered Through Subcutaneous Route in Healthy Adult Subjects (TPI-120)

Healthy Volunteers

United States
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Hebei Medical University Fourth Hospital

Unknown

Evaluate the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia After Chemotherapy in Patients With Non-Hodgkin's Lymphoma

Non Hodgkin's Lymphoma

China
Sun Yat-sen University

Recruiting

G-CSF in Patients With Anti-PD-1-axis Therapy-resistant Recurrent or Metastatic Nasopharyngeal Carcinoma

PD-1 Inhibitor | Granulocyte Colony-Stimulating Factor

China
Shandong University

Terminated

Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer

Ovarian Neoplasms | Ovarian Cancer | Adjuvant Chemotherapy

China
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Unknown

Evaluation of the Application of PEGylated Recombinant Human Granulocyte Stimulating Factor Injection (PEG-rhG-CSF) in Chemotherapy of Elderly Lymphoma Patients

Elderly Lymphoma Patients

China
Anhui Provincial Hospital

Unknown

Efficacy, Safety and Cost-effectiveness of PEG-rhG-CSF for Primary vs Secondary Prophylaxis

Chemotherapy-induced Neutropenia

China
wang shusen

Unknown

The Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced Neutropenia

Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Completed

The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and Adolescents

Acute Lymphoid Leukemia

China
Peking University

Unknown

The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy

Lymphoma | Mammary Cancer | Bone Tumour | Gynecological Tumors

China
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Peking University Cancer Hospital & Institute

Unknown

PEG-rhG-CSF in Elderly Patients With Small Cell Lung Cancer Receiving Chemotherapy

Small Cell Lung Cancer | PEG-rhG-CSF

China
Institute of Hematology & Blood Diseases Hospital

Recruiting

A Study of PEG-rhG-CSF and rhG-CSF Used for Aplastic Anemia Granulocyte Deficiency

Severe Aplastic Anemia

China
Mabwell (Shanghai) Bioscience Co., Ltd.

Completed

Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSF

Breast Cancer Female

China
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Completed

PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy to Prevent Neutropenia

Breast Cancer
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Completed

PEG-rhG-CSF in Patients With Lymphoma Receiving Chemotherapy

Lymphoma
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Unknown

Real World Study of PEG-rhG-CSF in Prevention of Chemotherapy-induced Neutropenia

Chemotherapy-induced Neutropenia | Myelosuppression
Afﬁliated Hospital of North Sichuan Medical College

Unknown

A Real World Study Evaluating the Clinical Application of PEG-rhG-CSF During Chemotherapy in Patients With Solid Tumors

Neutropenia

China
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Completed

PEG-rhG-CSF in Patients With Malignant Solid Tumors Receiving Chemotherapy

Malignant Solid Tumors
Xiaohua Wu MD

Not yet recruiting

Efficacy and Safety of PEG-rhG-CSF in the Prevention of Neutropenia After Chemo in Pts With Gynecological Malignancies

Gynecologic Malignant Tumor

China
MacroGenics

Terminated

Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML) (VOYAGE)

AML

United States, United Kingdom, Germany, Israel, Spain, France, Italy, Netherlands
Peking University

Completed

The Efficacy and Safety of PEG-rhG-CSF（Pegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive Chemotherapy

Breastcancer

China
Peking University

Completed

Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer

Breast Cancer | Neutropenia

China
ReveraGen BioPharma, Inc.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaborators

Completed

A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular Dystrophy

United States, Canada, United Kingdom, Sweden, Australia, Israel
Hospital del Niño "Dr. Federico Gomez Santos"

Completed

Early Sodium Intake in Preterm Newborns

Hyponatremia | Premature

Mexico
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Unknown

Efficacy and Safety of Pegylated Recombinant Human Granulocyte Stimulating Factor in Secondary Prevention of Albumin Paclitaxel Combined With S-1 in the First-line Treatment of Advanced Pancreatic Cancer

Advanced Pancreatic Cancer

China
GeneScience Pharmaceuticals Co., Ltd.
Third Military Medical University; Shanghai Jiao Tong University School of... and other collaborators

Completed

Efficacy and Safety Study of rhGM-CSF Gel to Treat Deep 2nd Thickness Burn (rhGM-CSF)

Deep Partial Thickness Burn
Chinese PLA General Hospital

Unknown

PEG-rhG-CSF in Secondary Prevention of Nab-Paclitaxel Combined With S-1 in Advanced Pancreatic Cancer

Pancreatic Cancer | PEG-rhG-CSF

China
Spanish Society of Critical Care Medicine and Coronary...

Recruiting

Efficacy and Safety of Administration of High Levels of Protein to Critically Ill Patients. (FISIO)

Intensive Care Unit Acquired Weakness

Spain
Shandong Provincial Hospital

Unknown

PEG-rhG-CSF in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy to Prevent Neutropenia

Lymphoma,Non-Hodgkin

China

3

Subscribe